TrialScope is part of Informa Pharma Intelligence, a division of Informa Business Intelligence, Inc. (IBI). IBI is a wholly-owned subsidiary of Informa PLC.

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

TrialScope’s Mike Wenger Named a 2020 PM360 ELITE 100 Patient Advocate


May 7, 2020

Vice President of Patient Engagement Cited for His Work on TrialScope Connect™ 

JERSEY CITY, NJ (May 6, 2020) — Mike Wenger, Vice President of Patient Engagement at TrialScope, has been named one of the 2020 PM360 ELITE 100 in the Patient Advocates category. The PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represents the most influential people in the healthcare industry today.  

Wenger is spearheading TrialScope Connect, an initiative that is destined to change the pharmaceutical industry paradigm for clinical trial recruitment. Drawing upon his expertise as a software developer and his own experience as a patient, Wenger is focused on using technology to better match and refer patients to clinical trials. 

TrialScope Connect is a patient referral collective and platform that brings together stakeholders – clinical trial sponsors, recruitment companies, patient advocacy groups and other unique health partners – to better match and refer patients to clinical trials. An industry first, TrialScope Connect is based on the concept of collaboration instead of competition, to accelerate medical breakthroughs and better health for all. 

“I am honored by this award, one that reaffirms the importance of demystifying clinical research and making trials more accessible to patients. These are critical steps in bringing cures and treatments to patients faster. The patient recruiting industry is ripe for disruption. Sponsors, recruiting partners and patients alike can benefit from a crowd-sourced approach that ensures trial opportunities are promoted in more places. Trial recruitment, like many parts of clinical development, needs greater data transparency.” 

The PM360 ELITE Awards were established recognize individuals who have made a significant impact on the healthcare industry. More than 500 submissions were received and nominees were evaluated and selected by the PM360 editorial staff based on their accomplishments; testimonials from their bosses, clients and colleagues; and supporting evidence that reflects the impact of their efforts. A total of 100 winners were selected across 18 categories. 

“At a time when the world is being impacted by a healthcare crisis in the COVID-19 pandemic, it is nice to be able to reflect on the extraordinary work those in the life sciences do to discover, develop and promote life-saving treatments,” said Anna Stashower, CEO and Publisher of PM360. “Our ELITE winners epitomize the very best of our industry. We are incredibly thankful for everything they do and proud to honor all of their achievements.”    

The winners are profiled in PM360’s May 2020 issue.  

For more information on TrialScope and TrialScope Connect, visit  

About TrialScope 

TrialScope is the global leader in clinical trial disclosure and transparency management technology, supporting 16 of the top 20 industry clinical trial sponsors worldwide. TrialScope provides proven solutions that optimize the efficiency of disclosure activities, maximize trial data transparency, and foster more informed, engaged patients through open research sharing. To learn more about TrialScope, visit  

About PM360 

PM360 is the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics and medical device sectors.